Christopher Bunick, MD, PhD: New Data on JAK Inhibitors for Atopic Dermatitis
Bunick describes the key safety data from new late-breaking research on upadacitinib for atopic dermatitis that he presented at the Revolutionizing Atopic Dermatitis conference.